Skip to main content
Top

Clinical and Experimental Nephrology

Issue 2/2005

Content (16 Articles)

REVIEW ARTICLE

Renal tubular transport and the genetic basis of hypertensive disease

Florian Lang, Giovambattista Capasso, Matthias Schwab, Siegfried Waldegger

ORIGINAL ARTICLE

Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-β produced by tubular epithelial cells in response to high glucose

Tatsuya Kobayashi, Tsutomu Inoue, Hirokazu Okada, Tomohiro Kikuta, Yoshihiko Kanno, Takashi Nishida, Masaharu Takigawa, Takeshi Sugaya, Hiromichi Suzuki

ORIGINAL ARTICLE

The Na+-excreting efficacy of indapamide in combination with furosemide in massive edema

Misa Tanaka, Emi Oida, Keiko Nomura, Fumiaki Nogaki, Atsushi Fukatsu, Kazuhide Uemura, Masatomo Yashiro, Takeshi Kimura, Eri Muso, Takahiko Ono

ORIGINAL ARTICLE

Glutathione peroxidase activity in patients with renal disorders

Mohamed A. El-far, Mohamed A. Bakr, Sami E. Farahat, Elsaid A. Abd El-Fattah

ORIGINAL ARTICLE

Prevalence of human polyoma virus (BK virus and JC virus) infection in patients with chronic renal disease

Tetsuya Kaneko, Toshiki Moriyama, Yoshiharu Tsubakihara, Masaru Horio, Enyu Imai

ORIGINAL ARTICLE

Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy

Norihiko Goto, Yoshihiro Tominaga, Susumu Matsuoka, Tetsuhiko Sato, Akio Katayama, Toshihito Haba, Kazuharu Uchida

ORIGINAL ARTICLE

Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism

Yuko Oyama, Junichiro James Kazama, Kentaro Omori, Noboru Higuchi, Shigemi Kameda, Suguru Yamamoto, Yumi Ito, Hiroki Maruyama, Ichiei Narita, Fumitake Gejyo

ORIGINAL ARTICLE

Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment

Ryo Yamamoto, Yasushi Otsuka, Masaaki Nakayama, Yukio Maruyama, Naohiko Katoh, Masato Ikeda, Hiroyasu Yamamoto, Keitaro Yokoyama, Yoshindo Kawaguchi, Masato Matsushima

ORIGINAL ARTICLE

Effects of low dialysate calcium concentration on health-related quality of life in hemodialysis patients

Yoshinori Taji, Takeshi Morimoto, Shunichi Fukuhara, Tsuguya Fukui, Takashi Kuwahara

ORIGINAL ARTICLE

High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis

Kazunobu Yoshimura, Hirofumi Nakano, Keitaro Yokoyama, Masaaki Nakayama

ORIGINAL ARTICLE

Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long-term prognosis

Ralf Schiel, Sebastian Heinrich, Thomas Steiner, Undine Ott, Günter Stein

CASE REPORT

Asymptomatic renal infarction, due to fibromuscular dysplasia, in a young woman with 11 years of follow-up

Shinichiro Niizuma, Hajime Nakahama, Takashi Inenaga, Fumiki Yoshihara, Satoko Nakamura, Masayoshi Yoshii, Kei Kamide, Takeshi Horio, Yuhei Kawano

CASE REPORT

ANCA-negative pauci-immune crescentic glomerulonephritis complicated with recurrent massive gastrointestinal hemorrhage

Tamaki Harada, Takashi Uzu, Tomoko Namba, Ryohei Yamamoto, Ken Takahara, Atsushi Yamauchi

CASE REPORT

Tuberous sclerosis, associated with renal cell carcinoma and angiomyolipoma, in a patient who developed endstage renal failure after nephrectomy

Yujiro Kida, Kenji Yamaguchi, Hitoe Suzuki, Eiichiro Kanda, Minoru Ando, Kenichi Ohashi, Nobuaki Funata, Hiroshi Saito

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.